Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
32%

OVERLAP
BY WEIGHT
18

# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
64%
ALSO IN BBP
BBP
57
HOLDINGS
30%
ALSO IN PBE
SECTOR DRIFT (PBE minus BBP)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in BBP
Overlap
IONIS PHARMACEUTICALS, INC. 4.2% 2.7% 2.7%
HALOZYME THERAPEUTICS INC 2.4% 2.6% 2.4%
MADRIGAL PHARMACEUTICALS, INC. 2.7% 2.4% 2.4%
ACADIA PHARMACEUTICALS INC 2.2% 2.4% 2.2%
GILEAD SCIENCES INC 4.6% 2.1% 2.1%
PBE Overweight Relative to BBP
ILLUMINA INC 4.8%
ROYALTY PHARMA PLC CLASS A 4.7%
BIOGEN IDEC INC 4.0%
REGENERON PHARMACEUTICALS 3.5%
VERTEX PHARMACEUTICALS INC 3.5%
VERACYTE INC 3.2%
EXACT SCIENCES CORP 3.1%
AMGEN INC 3.1%
SAREPTA THERAPEUTICS INC 2.9%
INCYTE CORP 2.8%
PBE Underweight Relative to BBP
INSMED INC -3.3%
BRIDGEBIO PHARMA, INC. -3.2%
ALNYLAM PHARMACEUTICALS INC -3.0%
RHYTHM PHARMACEUTICALS, INC. -3.0%
MIRUM PHARMACEUTICALS, INC. -3.0%
BEIGENE LTD. SPONSORED ADR -2.9%
INTRA-CELLULAR THERAPIES INC -2.6%
ASCENDIS PHARMA A/S -2.6%
PHATHOM PHARMACEUTICALS, INC. -2.5%
SAGE THERAPEUTICS INC -2.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY